P. K. Mazur Et Al. , "Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma," NATURE MEDICINE , vol.21, no.10, pp.1163-1171, 2015
Mazur, P. K. Et Al. 2015. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. NATURE MEDICINE , vol.21, no.10 , 1163-1171.
Mazur, P. K., Herner, A., Mello, S. S., Wirth, M., Hausmann, S., Sanchez-Rivera, F. J., ... Lofgren, S. M.(2015). Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. NATURE MEDICINE , vol.21, no.10, 1163-1171.
Mazur, Pawel Et Al. "Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma," NATURE MEDICINE , vol.21, no.10, 1163-1171, 2015
Mazur, Pawel K. Et Al. "Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma." NATURE MEDICINE , vol.21, no.10, pp.1163-1171, 2015
Mazur, P. K. Et Al. (2015) . "Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma." NATURE MEDICINE , vol.21, no.10, pp.1163-1171.
@article{article, author={Pawel K. Mazur Et Al. }, title={Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma}, journal={NATURE MEDICINE}, year=2015, pages={1163-1171} }